CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine
Author
A Fabi
AJ Redig
+47Â more
Amy Hobeika
AR Harper
B Hagen
B Miller
C Dardis
C Twelves
DA Berry
E Biskup
G Disibio
Guoliang Qiao
H Zembutsu
H. Kim Lyerly
HL McLeod
I Kock de
J Li
J O’Shaughnessy
J Ren
J Yu
JG Schrama
JN Patel
Jun Ren
M Heubner
M John
Michael A. Morse
N Abd El Wahab
N Dong
P Therasse
P Vici
Q Song
Qingkun Song
S Lakkireddy
S Rodenhuis
SA Scott
SF Huntington
SF Zhou
Thiotepa
TK Chang
V Jain
W Sadee
William R. Gwin
WJ Gradishar
X Wang
X Zhou
Xiaoli Wang
Xinna Zhou
YA Cho
Z Lu
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref